Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review</title><author><name sortKey="Bhatia, Kishor" sort="Bhatia, Kishor" uniqKey="Bhatia K" first="Kishor" last="Bhatia">Kishor Bhatia</name><affiliation><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD</nlm:aff></affiliation></author><author><name sortKey="Shiels, Meredith S" sort="Shiels, Meredith S" uniqKey="Shiels M" first="Meredith. S." last="Shiels">Meredith. S. Shiels</name><affiliation><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD</nlm:aff></affiliation></author><author><name sortKey="Berg, Alexandra" sort="Berg, Alexandra" uniqKey="Berg A" first="Alexandra" last="Berg">Alexandra Berg</name><affiliation><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD</nlm:aff></affiliation></author><author><name sortKey="Engels, Eric A" sort="Engels, Eric A" uniqKey="Engels E" first="Eric. A." last="Engels">Eric. A. Engels</name><affiliation><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">22729152</idno><idno type="pmc">3418441</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418441</idno><idno type="RBID">PMC:3418441</idno><idno type="doi">10.1097/CCO.0b013e328355e115</idno><date when="2012">2012</date><idno type="wicri:Area/Pmc/Corpus">003878</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003878</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review</title><author><name sortKey="Bhatia, Kishor" sort="Bhatia, Kishor" uniqKey="Bhatia K" first="Kishor" last="Bhatia">Kishor Bhatia</name><affiliation><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD</nlm:aff></affiliation></author><author><name sortKey="Shiels, Meredith S" sort="Shiels, Meredith S" uniqKey="Shiels M" first="Meredith. S." last="Shiels">Meredith. S. Shiels</name><affiliation><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD</nlm:aff></affiliation></author><author><name sortKey="Berg, Alexandra" sort="Berg, Alexandra" uniqKey="Berg A" first="Alexandra" last="Berg">Alexandra Berg</name><affiliation><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD</nlm:aff></affiliation></author><author><name sortKey="Engels, Eric A" sort="Engels, Eric A" uniqKey="Engels E" first="Eric. A." last="Engels">Eric. A. Engels</name><affiliation><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD</nlm:aff></affiliation></author></analytic><series><title level="j">Current opinion in oncology</title><idno type="ISSN">1040-8746</idno><idno type="eISSN">1531-703X</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec id="S1"><title>Purpose of review</title><p id="P1">In immunodeficiency, an increased sarcoma risk is confirmed for Kaposi’s sarcoma. Whether rates of other sarcoma subtypes are elevated in the setting of immunodeficiency is not known. We therefore reviewed published case reports on HIV/AIDS patients and organ transplant recipients with sarcomas. For comparison, we assessed sarcomas in the U.S. general population using Surveillance Epidemiology End Results (SEER) data.</p></sec><sec id="S2"><title>Findings</title><p id="P2">One hundred seventy-six non-KS sarcomas were identified, 75 in people with HIV/AIDS and 101 in transplant recipients. Leiomyosarcomas (n=101) were the most frequently reported sarcomas, followed by angiosarcomas (n=23) and fibrohistiocytic tumors (n=17). Leiomyosarcomas were reported with two age peaks, in children and young adults. Epstein-Barr virus (EBV) was detected in the tumor cells in 85% and 88% of leiomyosarcomas in HIV-infected people and transplant recipients, respectively. Angiosaromas and fibrohistiocytic tumors were most frequently reported in males. Among kidney transplant recipients, 20% of sarcomas arose at the site of an arteriovenous fistula. In comparison, leiomyoscarcomas, angiosarcomas, and fibrohistiocytic tumors comprised 16.9%, 3.8%, and 18.7% of sarcomas in the U.S. general population.</p></sec><sec id="S3"><title>Summary</title><p id="P3">Leiomyosarcoma and angiosarcoma may occur disproportionately in immunodeficiency. Leiomyosarcomas appear etiologically linked to EBV while angiosarcomas might be correlated with an arteriovenous fistula. Additional studies are necessary to understand the contribution of immunodeficiency to the etiology of these sarcomas.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">9007265</journal-id><journal-id journal-id-type="pubmed-jr-id">1063</journal-id><journal-id journal-id-type="nlm-ta">Curr Opin Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Curr Opin Oncol</journal-id><journal-title-group><journal-title>Current opinion in oncology</journal-title></journal-title-group><issn pub-type="ppub">1040-8746</issn><issn pub-type="epub">1531-703X</issn></journal-meta><article-meta><article-id pub-id-type="pmid">22729152</article-id><article-id pub-id-type="pmc">3418441</article-id><article-id pub-id-type="doi">10.1097/CCO.0b013e328355e115</article-id><article-id pub-id-type="manuscript">NIHMS377638</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bhatia</surname><given-names>Kishor</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shiels</surname><given-names>Meredith. S.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Berg</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Engels</surname><given-names>Eric. A.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD</aff><author-notes><corresp id="FN1">Correspondence: Dr. Kishor Bhatia, Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Rockville, MD 20892. Phone: Phone: 301-496-8115, Fax: 301-402-0817, <email>bhatiak@mail.nih.gov</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>1</day><month>6</month><year>2012</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2012</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>9</month><year>2013</year></pub-date><volume>24</volume><issue>5</issue><fpage>537</fpage><lpage>546</lpage><abstract><sec id="S1"><title>Purpose of review</title><p id="P1">In immunodeficiency, an increased sarcoma risk is confirmed for Kaposi’s sarcoma. Whether rates of other sarcoma subtypes are elevated in the setting of immunodeficiency is not known. We therefore reviewed published case reports on HIV/AIDS patients and organ transplant recipients with sarcomas. For comparison, we assessed sarcomas in the U.S. general population using Surveillance Epidemiology End Results (SEER) data.</p></sec><sec id="S2"><title>Findings</title><p id="P2">One hundred seventy-six non-KS sarcomas were identified, 75 in people with HIV/AIDS and 101 in transplant recipients. Leiomyosarcomas (n=101) were the most frequently reported sarcomas, followed by angiosarcomas (n=23) and fibrohistiocytic tumors (n=17). Leiomyosarcomas were reported with two age peaks, in children and young adults. Epstein-Barr virus (EBV) was detected in the tumor cells in 85% and 88% of leiomyosarcomas in HIV-infected people and transplant recipients, respectively. Angiosaromas and fibrohistiocytic tumors were most frequently reported in males. Among kidney transplant recipients, 20% of sarcomas arose at the site of an arteriovenous fistula. In comparison, leiomyoscarcomas, angiosarcomas, and fibrohistiocytic tumors comprised 16.9%, 3.8%, and 18.7% of sarcomas in the U.S. general population.</p></sec><sec id="S3"><title>Summary</title><p id="P3">Leiomyosarcoma and angiosarcoma may occur disproportionately in immunodeficiency. Leiomyosarcomas appear etiologically linked to EBV while angiosarcomas might be correlated with an arteriovenous fistula. Additional studies are necessary to understand the contribution of immunodeficiency to the etiology of these sarcomas.</p></sec></abstract><kwd-group><kwd>HIV</kwd><kwd>AIDS</kwd><kwd>organ transplant</kwd><kwd>cancer</kwd><kwd>EBV</kwd><kwd>HIV</kwd><kwd>sarcoma. HHV-8</kwd></kwd-group><funding-group><award-group><funding-source country="United States">Division of Cancer Epidemiology and Genetics : NCI</funding-source><award-id>Z01 CP010150-08 || CP</award-id></award-group></funding-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003878 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 003878 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.31. |  |